PPARgamma/NN
activation/NN
induces/VBZ
the/DT
expression/NN
of/IN
the/DT
adipocyte/NN
fatty/JJ
acid/NN
binding/NN
protein/NN
gene/NN
in/IN
human/JJ
monocytes/NNS
./.

The/DT
peroxisome-proliferator/NN
activated/JJ
receptor/NN
gamma/NN
(/(
PPARgamma/NN
)/)
,/,
a/DT
member/NN
of/IN
the/DT
nuclear/JJ
receptor/NN
superfamily/NN
of/IN
ligand/NN
activated/JJ
transcription/NN
factors/NNS
,/,
plays/VBZ
a/DT
key/JJ
role/NN
in/IN
the/DT
anti-diabetic/JJ
actions/NNS
of/IN
the/DT
thiazolidinediones/NNS
(/(
TZDs/NNS
)/)
./.
=====
PPARgamma/NN
induces/VBZ
the/DT
expression/NN
of/IN
many/JJ
genes/NNS
involved/VBN
in/IN
lipid/NN
anabolism/NN
,/,
including/VBG
the/DT
adipocyte/NN
fatty/JJ
acid/NN
binding/NN
protein/NN
(/(
aP2/NN
)/)
,/,
and/CC
is/VBZ
a/DT
key/JJ
regulator/NN
of/IN
adipocyte/JJ
differentiation/NN
./.
=====
PPARgamma/NN
is/VBZ
also/RB
expressed/VBN
in/IN
hematopoietic/JJ
cells/NNS
and/CC
is/VBZ
up-regulated/VBN
in/IN
activated/VBN
monocytes/macrophages/NNS
./.
=====
Activation/NN
of/IN
PPARgamma/NN
may/MD
play/VB
a/DT
role/NN
in/IN
the/DT
induction/NN
of/IN
differentiation/NN
of/IN
macrophages/NNS
to/TO
foam/NN
cells/NNS
that/WDT
are/VBP
associated/VBN
with/IN
atherosclerotic/JJ
lesions/NNS
./.
=====
We/PRP
report/VBP
that/IN
both/CC
natural/JJ
and/CC
synthetic/JJ
PPARgamma/NN
agonists/NNS
induce/VBP
time-/NN
and/CC
dose-dependent/JJ
increases/NNS
in/IN
aP2/NN
mRNA/NN
in/IN
both/CC
primary/JJ
human/JJ
monocytes/NNS
and/CC
the/DT
monocytic/JJ
cell/NN
line/NN
,/,
THP-1/NN
./.
=====
These/DT
data/NNS
suggest/VBP
that/IN
PPARgamma/NN
activation/NN
may/MD
play/VB
a/DT
role/NN
in/IN
monocyte/NN
differentiation/NN
and/CC
function/VB
analogous/JJ
to/TO
its/PRP$
well-characterized/JJ
role/NN
in/IN
adipocytes/NNS
./.